Varmora Granito targets ₹2,500 crore revenue potential by FY29
The tile maker says it has completed ₹450 crore of capex across FY24 and FY25. It plans to use part of its ₹708 crore IPO proceeds to repay ₹240 crore in net debt and is shifting toward premium tiles and lab-grown marble.
The development
Varmora Granito projects ₹2,500 crore revenue potential by FY29 after completing ₹450 crore capex across FY24 and FY25. It plans to repay ₹240 crore net debt using part of its ₹708 crore IPO proceeds, while shifting toward premium tiles and lab-grown marble.
The numbers
- ₹2,500 crore
- FY29
- ₹450 crore
- FY24
- FY25
- ₹708 crore
- ₹240 crore
- ₹40 crore
- ₹20 crore
- ₹85 crore
- ₹105 crore
- 2.5 times
- ₹800 crore to ₹900 crore
- 18.5%-19.2%
- 9.5%
- 10%
- ₹250 crore
- ₹55 crore
- 57%
- FY23
- 84%
- 95%
- ₹41,000 crore-₹42,000 crore
- ₹19 crore
- 96 days
- 75-80 days
- 3,063
- ₹90 per cubic metre
Why it matters to operators and investors
Varmora’s push into premium tiles and lab-grown marble signals a strategic move up the value chain, worth tracking for its impact on category competition and partnership opportunities.
What to watch next
- Quarterly revenue growth and capacity utilization relative to the FY29 ambition.
- Premium-product share, average selling price, and gross margin trends.
- Dealer additions, repeat orders, and evidence of lab-grown marble adoption.
- Net debt, interest expense, and working-capital intensity after the planned repayment.
- Industry discounting, tile demand, and any fresh capex that could increase supply ahead of demand.
- Use IPO proceeds as planned to repay ₹240 crore in net debt, while retaining funds for growth and working capital.
- Ramp the FY24–FY25 capex in stages and prioritize utilization before committing to another major capacity expansion.
- Broaden dealer reach and product placement for premium tiles and lab-grown marble, where realization and adoption matter as much as volume.
- Track whether higher-end sales improve margins and cash conversion rather than relying on revenue growth alone.
The counter-case
₹2,500 crore by FY29 is a target, not a forecast or evidence of realized growth. The signal gives no current revenue baseline, so the implied growth rate is unclear. Premium tiles and lab-grown marble may require execution, demand, and margin gains that are far from assured; completed capex and debt repayment do not guarantee returns.